|
PHF20L1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.276700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.422700E-03 |
| Normal-vs-Stage2 |
4.526800E-01 |
| Normal-vs-Stage3 |
1.002230E-02 |
| Normal-vs-Stage4 |
8.063400E-03 |
| Stage1-vs-Stage2 |
4.661800E-01 |
| Stage1-vs-Stage3 |
5.489000E-01 |
| Stage1-vs-Stage4 |
4.614600E-01 |
| Stage2-vs-Stage3 |
2.936800E-01 |
| Stage2-vs-Stage4 |
2.831800E-01 |
| Stage3-vs-Stage4 |
9.267800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.360000E-03 |
| Normal-vs-AfricanAmerican |
1.418180E-02 |
| Normal-vs-Asian |
8.581600E-01 |
| Caucasian-vs-AfricanAmerican |
7.208400E-01 |
| Caucasian-vs-Asian |
3.551000E-01 |
| AfricanAmerican-vs-Asian |
2.390200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.918050E-03 |
| Normal-vs-Female |
2.329700E-02 |
| Male-vs-Female |
4.469400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.035900E-03 |
| Normal-vs-Age(41-60Yrs) |
4.079800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.297110E-03 |
| Normal-vs-Age(81-100Yrs) |
9.994400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.928000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.116000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.617400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.981010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.223600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.559600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.137400E-01 |
| Normal-vs-Grade 2 |
1.245210E-01 |
| Normal-vs-Grade 3 |
1.030090E-04 |
| Normal-vs-Grade 4 |
1.182900E-03 |
| Grade 1-vs-Grade 2 |
3.252000E-01 |
| Grade 1-vs-Grade 3 |
2.195800E-02 |
| Grade 1-vs-Grade 4 |
3.226000E-02 |
| Grade 2-vs-Grade 3 |
1.891920E-02 |
| Grade 2-vs-Grade 4 |
4.089800E-02 |
| Grade 3-vs-Grade 4 |
7.214200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.381900E-02 |
| Normal-vs-ccB subtype |
2.974500E-02 |
| ccA subtype-vs-ccB subtype |
6.459800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.644400E-02 |
| Normal-vs-N1 |
1.726970E-01 |
| N0-vs-N1 |
6.680000E-01 |
|
|
